天宇股份 (300702)
Zhejiang Tianyu Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 34797.72
- Circulating A-Shares(W): 21116.45
- Earnings Per Share(RMB): 0.6300
- Net Assets Per Share(RMB): 10.6912
- Operating Revenue(W RMB): 228698.11
- Total Profit(W RMB): 23499.73
- Net Profit Attributable to Parent(W RMB): 22093.30
- Net Profit Growth Rate(%): 159.57
- Weighted Return on Equity(%): 6.1200
- Operating Cash Flow Per Share(RMB): 0.6190
- Undistributed Profit Per Share(RMB): 5.3825
- Capital Reserve Per Share(RMB): 4.0950
2. Main Business
The main business covers:
- Research, production, and sales of intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms.
3. Company Basic Information
- Company Name: Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Listing Date: 2017-09-19
- Industry: Pharmaceutical Manufacturing
- Address: Huangyan Jiangkou Chemical Development Zone, Taizhou City, Zhejiang Province
- Website: www.tianyupharm.com
- Company Profile:The company's predecessor, Zhejiang Tianyu Pharmaceutical Chemical Co., Ltd., was established on February 14, 2003. On April 8, 2011, the company resolved to transform into a joint stock company. The company is primarily engaged in the research, production, and sales of intermediates, APIs, and finished dosage forms.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Jiangsu Zhaoxin Private Fund Management Co., Ltd. - Zhaoxin Liaowang No.1 Private Securities Investment Fund | Private Securities Investment Fund | 2154.49 | 10.20 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 614.40 | 2.91 |
| 3 | Zhejiang Tianyu Pharmaceutical Co., Ltd. - 2024 Employee Stock Ownership Plan | Asset Management Plan | 355.01 | 1.68 |
| 4 | Guotai Jiatai Equity Special Pension Product - China Merchants Bank Co., Ltd. | Asset Management Plan | 330.09 | 1.56 |
| 5 | Golden Eagle Fund - Tibet Trust - Jintong No.33 Collective Fund Trust Plan - Golden Eagle Youxuan No.210 Single Asset Management Plan | Asset Management Plan | 236.62 | 1.12 |
| 6 | Guotai Asset Management Co., Ltd. - Social Security Fund 2103 Portfolio | Social Security Fund | 229.25 | 1.09 |
| 7 | Xinao Pharmaceutical Health Hybrid Securities Investment Fund A Class | Fund | 56.65 | 0.27 |
| 8 | Xinao Small and Medium Cap Hybrid Securities Investment Fund A Class | Fund | 33.11 | 0.16 |
| 9 | Xiangcai Pharmaceutical Health Hybrid Securities Investment Fund A Class | Fund | 27.38 | 0.13 |
| 10 | Orient CSI A500 Index Enhanced Securities Investment Fund A Class | Fund | 16.50 | 0.08 |
5. Concept Sectors
- CXO Concept
- Synthetic Biology
- High-Performance Stocks
- Heavily Held by Private Funds
- Chuangye 200 Index
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information
